$750 Million Investment in Australia’s Medical Future.  The Australian government is making a significant investment in medical research with the Clinical Trials Activity initiative.  This 10-year, $750 million program will fund national and international clinical trials, providing researchers with the resources they need to develop new treatments for a wide range of conditions.

The focus of this initiative is on:

  • clinical trials addressing rare cancers, rare diseases, and unmet needs
  • bringing investigator-led international clinical trials to Australia
  • effective health interventions (i.e. research projects focused on implementation science and comparative effectiveness research).

The initiative will also fund research projects focused on any disease or condition that meets the objective specified in each grant opportunity.

Read the full details here.

BS3 is proud to assist companies conducting clinical trials here in Australia by providing comprehensive services that help streamline the process and assist with bringing new treatments to market faster.  Our expertise in clinical trial management enables us to support companies navigating the complexities of this important work.